U.S. Biotechnology Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus News Biotechnology
Dare Bioscience Inc (DARE) Q3 2024 Earnings Call Highlights: Strategic Advancements and Financial Challenges
Dare Bioscience Inc (DARE) secures significant funding and progresses with FDA interactions, despite facing increased operational costs and financial hurdles. Nov 15, 2024
GuruFocus News Biotechnology
Plus Therapeutics Inc (PSTV) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges and Advancing Clinical Programs
Despite a decrease in cash reserves, Plus Therapeutics Inc (PSTV) reports progress in clinical trials and secures significant grant funding to support future growth. Nov 15, 2024
GuruFocus News Biotechnology
Panbela Therapeutics Inc (PBLA) Q3 2024 Earnings Call Highlights: Strategic Loan and Clinical Progress Amid Financial Challenges
Panbela Therapeutics Inc (PBLA) secures a $12 million loan to bolster clinical trials, but faces liquidity concerns and financial hurdles. Nov 15, 2024
GuruFocus News Biotechnology
Palatin Technologies Inc (PTN) Q1 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Challenges
Palatin Technologies Inc (PTN) navigates a transformative quarter with a focus on obesity programs and strategic partnerships despite a significant revenue drop. Nov 15, 2024
GuruFocus News Biotechnology
Ocular Therapeutix Inc (OCUL) Q3 2024 Earnings Call Highlights: Strong Financial Position and Promising Clinical Progress
Ocular Therapeutix Inc (OCUL) reports robust cash reserves and significant trial advancements, despite regulatory and pricing challenges. Nov 15, 2024